USPTO Examiner LOPEZLIRA ASHLEY NICOLE - Art Unit 1799

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19248101APPARATUS FOR TISSUE TRANSPORT AND PRESERVATIONJune 2025January 2026Allow711YesNo
18184130SENSING DEVICE AND METHOD OF DETECTING TARGET SUBSTANCEMarch 2023March 2026Allow3611NoNo
17793861DEVICES AND METHODS FOR TRANSFECTION AND FOR GENERATION OF CLONAL POPULATIONS OF CELLSJuly 2022March 2026Abandon4310NoNo
17782598MICROFLUIDIC REACTION CHAMBER WITH A REACTION CHAMBER CIRCUITJune 2022December 2025Allow4311NoNo
17781791ALTERNATING TANGENTIAL FLOW BIOREACTOR WITH HOLLOW FIBER SYSTEM AND METHOD OF USEJune 2022December 2025Abandon4301NoNo
17760811MILLIFLUIDIC DEVICE FOR ADVANCED CULTURES OF BIOLOGICAL AGENTSMarch 2022September 2025Allow4220NoNo
17690054CELL CULTURE CHIP, CELL CULTURE APPARATUS, AND CELL CULTURE METHODMarch 2022October 2025Allow4420NoNo
17640970CELL CULTURE SHEET AND LARGE-CAPACITY CELL CULTURE DEVICE INCLUDING SAMEMarch 2022August 2025Allow4120NoNo
17753497CELL SCREENING DEVICE AND CELL SCREENING KITMarch 2022July 2025Allow4020NoNo
17678729FLUIDIC PLATFORMS FOR PERFUSABLE VASCULARIZED TISSUES WITH INFILTRATESFebruary 2022July 2025Allow4111NoNo
17676423BUOYANT PHOTOBIOREACTOR ARRANGEMENTFebruary 2022September 2025Abandon4320NoNo
17666795FILTRATION AND COLLECTION DEVICEFebruary 2022December 2025Allow4620YesNo
17666010KIDNEY COOLING SYSTEMFebruary 2022October 2025Allow4411NoNo
17627075SYSTEMS AND METHODS FOR PERFUSION CONTROL IN BIOREACTORSJanuary 2022January 2026Abandon4921NoNo
17646601Carbon-Negative BioplasticDecember 2021June 2025Allow4130YesNo
17623391BIOREACTOR SYSTEMSDecember 2021May 2025Allow4011YesNo
17623591CELL CULTURE VESSEL AND CELL CULTURE DEVICEDecember 2021September 2025Abandon4520NoNo
17562190MICROORGANISM SCREENING SYSTEM AND MICROORGANISM SCREENING METHODDecember 2021July 2025Abandon4201NoNo
17553568Method and Apparatus for Rapid Virus Screening and Detection using a CanineDecember 2021May 2025Abandon4110NoNo
17547955SEGMENTED CULTURE DISH AND IMPRINTING SYSTEMDecember 2021May 2025Abandon4110NoNo
17617747BIOREACTOR SUPPORT SYSTEMDecember 2021July 2025Allow4321YesNo
17541436Continuously Expanding Volume BioreactorDecember 2021August 2025Allow4430NoNo
175375253D MULTI-ORGAN CO-CULTURE CHIPNovember 2021October 2025Allow4730NoNo
17533463CELLULAR CASSETTES FOR THE COLLECTION, STORAGE, AND ANALYSIS OF BIOLOGICAL SAMPLESNovember 2021November 2025Abandon4801NoNo
17524168SYSTEMS FOR INTRACELLULAR DELIVERY OF MOLECULES FROM A CELL MEDIUM INTO CELLSNovember 2021December 2025Abandon5030NoNo
17513007Electroporation Devices And Methods Of Cell TransfectionOctober 2021November 2025Allow4921YesNo
17606109DEVICE FOR MECHANICALLY STABILIZING A CONNECTION, IN PARTICULAR A SENSOR CONNECTION, ON A FLEXIBLE BAGOctober 2021November 2025Allow4930NoNo
17508193MICROPLATES FOR AUTOMATING ORGANOID CULTIVATIONOctober 2021August 2025Allow4640YesNo
17503591Container w/ Heat PlateOctober 2021August 2025Abandon4620NoNo
17604290METHOD FOR CULTIVATING MICROALGAL BIOMASS AND APPARATUS FOR THE IMPLEMENTATION THEREOFOctober 2021January 2026Abandon5121NoNo
17449281Integrated Bioreactor Apparatus for Fabricating Polyhydroxyalkanoate Bioplastic ProductsSeptember 2021March 2025Abandon4210NoNo
17471831Biological Sample Imaging DeviceSeptember 2021June 2025Allow4530YesNo
17468142APPARATUS FOR TISSUE TRANSPORT AND PRESERVATIONSeptember 2021August 2025Abandon4810NoNo
17446953Systems and Methods for Processing TissueSeptember 2021November 2025Allow5020NoNo
17429962SINGLE CELL TRANSFECTION WITH INTERCHANGEABLE REAGENTAugust 2021March 2026Allow5541YesNo
17369490Systems and Methods for Determining Probative Samples and Isolation and Quantitation of CellsJuly 2021April 2025Abandon4501NoNo
17419182CELL PROCESSING CONTAINER, CELL PROCESSING SYSTEM AND METHODS OF USE THEREOFJune 2021September 2025Abandon5120NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner LOPEZLIRA, ASHLEY NICOLE - Prosecution Strategy Guide

Executive Summary

Examiner LOPEZLIRA, ASHLEY NICOLE works in Art Unit 1799 and has examined 23 patent applications in our dataset. With an allowance rate of 47.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.

Allowance Patterns

Examiner LOPEZLIRA, ASHLEY NICOLE's allowance rate of 47.8% places them in the 11% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by LOPEZLIRA, ASHLEY NICOLE receive 1.96 office actions before reaching final disposition. This places the examiner in the 48% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by LOPEZLIRA, ASHLEY NICOLE is 46 months. This places the examiner in the 11% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +75.0% benefit to allowance rate for applications examined by LOPEZLIRA, ASHLEY NICOLE. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 38.5% of applications are subsequently allowed. This success rate is in the 88% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 0% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Petition Practice

When applicants file petitions regarding this examiner's actions, 133.3% are granted (fully or in part). This grant rate is in the 96% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 8% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 9% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.